Researchers continue to excited about the medication , a groundbreaking dual treatment showing remarkable data in initial trials for weight loss . It works by targeting both pathways : GLP-1 and GIP, https://jadaqecy059232.losblogos.com/39579539/the-new-hope-for-weight-loss